Dr. Ajlan Al Zaki Director of Burjeel Hematology Oncology & Cellular Therapy Center
Years of Experience : 9
Nationality : United Arab Emirates
Languages Known : English, Arabic
Book AppointmentBiography
Dr. Ajlan Al Zaki is a highly accomplished UAE national and a triple Board-Certified Hematologist and Oncologist with extensive expertise in hematologic malignancies, immunotherapy, and cellular therapies. He currently serves as the Director of Burjeel Hematology Oncology & Cellular Therapy Center, where he specializes in cutting-edge treatments such as CAR T-cell therapy and advanced immunotherapies for complex hematologic conditions, including leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). Dr. Al Zaki is not only a practicing clinician but also a distinguished physician-scientist with nearly two decades of experience in clinical practice, research, and education in the United States. His career has been marked by significant contributions to the field of oncology, particularly in personalized cancer treatments, novel lymphoma strategies, and molecular imaging techniques. Prior to his role at Burjeel Medical City, he held prestigious positions at MD Anderson Cancer Center as an Instructor in the Department of Lymphoma/Myeloma and Cancer Systems Imaging. He was also a co-primary investigator on multiple clinical trials aimed at advancing cancer treatment methodologies. Dr. Al Zaki’s research focuses on immunotherapy-related adverse events and the development of innovative approaches to cancer care. He has led and collaborated on several high-impact research projects funded by the National Institutes of Health (NIH) and the National Cancer Institute (NCI). His expertise extends to clinical trial design, where he has contributed to groundbreaking studies that have shaped modern oncology practices. With an impressive academic background spanning chemical engineering, bioengineering, medicine, and specialized training in hematology and oncology, Dr. Al Zaki is dedicated to delivering exceptional patient care while advancing scientific knowledge in his field. His achievements have been recognized through numerous awards, including the Waun Ki Hong Award for Achievement in Basic Science Research during his fellowship at MD Anderson Cancer Center.
Awards & Achievements
- First Emirati inducted into the Alpha Omega Alpha Honor Society
- Member of the Translational Investigator Physician-Scientist Program
- Waun Ki Hong Award for Achievement in Basic Science Research
- Howard Hughes Medical Institute Scholar
- Solomon Pollack Award for Excellence in Bioengineering Research
Research & Publications
- Immunotherapy-related adverse events
- Molecular imaging techniques for cancer diagnosis and treatment
- Development of novel lymphoma treatment strategies
Education & Training
- BS in Chemical Engineering with Honors and Highest Distinction – Purdue University
- PhD in Bioengineering – University of Pennsylvania
- MD – George Washington University School of Medicine
- Internal Medicine Residency – Stanford University School of Medicine
- Hematology and Oncology Fellowship – MD Anderson Cancer Center
Expertise
- CAR T-cell therapy
- Advanced immunotherapies
- Complex hematologic malignancies (leukemias, lymphomas, multiple myeloma, MDS, MPNs)
- Personalized cancer treatments for lung cancer, anemia, and solid tumors
- Immunotherapy-related adverse events
- Molecular imaging techniques
- Novel lymphoma treatment strategies
- Clinical trial design
Blogs
Detecting Early Symptoms of Breast Cancer: A Guide for Women
Read more
Kidney Cancer – Symptoms, Causes & Treatment
Read more
Cervical Cancer – Symptoms, Causes & Treatment
Read more
